These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 1337444)

  • 1. The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates.
    Meldrum BS; Craggs MD; Dürmüller N; Smith SE; Chapman AG
    Epilepsy Res Suppl; 1992; 9():307-11. PubMed ID: 1337444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats.
    Borowicz KK; Duda AM; Kleinrok Z; Czuczwar SJ
    Pol J Pharmacol; 2001; 53(2):101-8. PubMed ID: 11787948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy.
    Smith SE; Dürmüller N; Meldrum BS
    Eur J Pharmacol; 1991 Aug; 201(2-3):179-83. PubMed ID: 1686756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.
    Dürmüller N; Craggs M; Meldrum BS
    Epilepsy Res; 1994 Feb; 17(2):167-74. PubMed ID: 8194512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.
    Namba T; Morimoto K; Sato K; Yamada N; Kuroda S
    Brain Res; 1994 Feb; 638(1-2):36-44. PubMed ID: 8199874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
    Turski L; Stephens DN; Jensen LH; Petersen EN; Meldrum BS; Patel S; Hansen JB; Löscher W; Schneider HH; Schmiechen R
    J Pharmacol Exp Ther; 1990 Apr; 253(1):344-52. PubMed ID: 1970362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD; Jacobsen P; Honoré T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticonvulsant effects of bifemelane hydrochloride on kindled seizures from the amygdala and hippocampus in rats].
    Nakamura Y; Morimoto K; Moriwake T; Okamoto M; Sato K; Hirayasu Y; Katayama K; Onishi M; Otsuki S
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):241-4. PubMed ID: 2816097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The opposite role of hippocampal mGluR1 in fear conditioning in kindled and non-kindled rats.
    Maciejak P; Lehner M; Turzyńska D; Szyndler J; Bidziński A; Taracha E; Sobolewska A; Walkowiak J; Skórzewska A; Wisłowska A; Hamed A; Płaźnik A
    Brain Res; 2008 Jan; 1187():184-93. PubMed ID: 18022605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
    Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V
    J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Turski L; Jacobsen P; Honoré T; Stephens DN
    J Pharmacol Exp Ther; 1992 Feb; 260(2):742-7. PubMed ID: 1371159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy.
    Löscher W; Rundfeldt C; Hönack D
    Eur J Neurosci; 1993 Nov; 5(11):1545-50. PubMed ID: 7904524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of NMDA receptors in epilepsy: II. Effects of NMDA receptor antagonists (CPP and MK-801) on hippocampal long-term potentiation in anesthetized rats.
    Morimoto K; Katayama K; Sato K; Ohnishi M; Okamoto M; Otsuki S
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):453-4. PubMed ID: 2175367
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticonvulsant effect of A1 but not A2A adenosine receptors of piriform cortex in amygdala-kindled rats.
    Rezvani ME; Mirnajafi-Zadeh J; Fathollahi Y; Palizvan MR
    Can J Physiol Pharmacol; 2007 Jun; 85(6):606-12. PubMed ID: 17823622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.
    Löscher W
    Prog Neurobiol; 1998 Apr; 54(6):721-41. PubMed ID: 9560847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation of the substantia nigra pars reticulata exerts long lasting suppression of amygdala-kindled seizures.
    Shi LH; Luo F; Woodward D; Chang JY
    Brain Res; 2006 May; 1090(1):202-7. PubMed ID: 16647692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subregional changes in discharge rate, pattern, and drug sensitivity of putative GABAergic nigral neurons in the kindling model of epilepsy.
    Gernert M; Fedrowitz M; Wlaz P; Löscher W
    Eur J Neurosci; 2004 Nov; 20(9):2377-86. PubMed ID: 15525279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.